Gunderson Capital Management Inc. has filed its 13F form on July 11, 2024 for Q2 2024 where it was disclosed a total value porftolio of $221 Million distributed in 39 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $20.2M, Novo Nordisk A S with a value of $15.4M, Nvidia Corp with a value of $14.1M, Microsoft Corp with a value of $12.8M, and Asml Holding Nv with a value of $12.2M.

Examining the 13F form we can see an increase of $5.82M in the current position value, from $215M to 221M.

Below you can find more details about Gunderson Capital Management Inc. portfolio as well as his latest detailed transactions.

Portfolio value $221 Million
Technology: $81.7 Million
Healthcare: $39.4 Million
Consumer Cyclical: $31.7 Million
Financial Services: $23.6 Million
Communication Services: $22.6 Million
Industrials: $6.28 Million
Consumer Defensive: $6.05 Million
Utilities: $5.67 Million
Other: $3.81 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 39
  • Current Value $221 Million
  • Prior Value $215 Million
  • Filing
  • Period Q2 2024
  • Filing Date July 11, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 12 stocks
  • Additional Purchases 21 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Gunderson Capital Management Inc. Portfolio

Follow Gunderson Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gunderson Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gunderson Capital Management Inc. with notifications on news.